SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cyberonics (cybx) epilepsy therapy recommonded -- Ignore unavailable to you. Want to Upgrade?

To: Valentin who wrote (153)3/15/1998 10:15:00 AM
From: yehuda fruchter  Read Replies (1) | Respond to of 471
 
to all,
Supposedly the lockup period has ended for Saint Jude Medical, which owns a significant portion of CYBX. This might have caused the selling pressure in the stock. However, who really care who is selling or buying this stock. The key here is the next quarterly report. Does CYBX again beat analyst expectations for sales (the highest now is $5 million) or not? If they do analyst will raise their price targets and the stock will move up, irregardless of who wants to sell or not. If they don't the stock will start coming back down again. Forget about price movements until then, they are entirely misleading.



To: Valentin who wrote (153)3/15/1998 1:58:00 PM
From: Dennis  Respond to of 471
 
Valentin, thanks for info and financials BUT I thought each unit was selling for $8,000. per. I called and e mailed the co. and asked when they expect approval in asia and when do they report earnings this quarter. I'll post if and when I get an answer.

Maybe the Beatles song is Helter Skelter. :o)


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News